Invesco's Andrew Lo Retires — What the Factor Stack Says at $33

Invesco's Andrew Lo is retiring. After 32 years building the firm's Asia Pacific business, the Senior Managing Director and Head of Asia Pacific will step down on March 31, 2027, handing the role to Marty Franc, who has spent 13 years at Invesco currently overseeing Australia, Greater China, and Southeast Asia.

The headline sounds like disruption. The details tell a different story — this is planned internal succession with a six-month overlap. Lo becomes Chairman Emeritus and stays on the boards of Invesco's China and India joint ventures. Franc isn't an outside hire; he already runs the businesses Lo built.

If you're here because of the leadership announcement, the news is continuity. If you're here because Invesco's stock (IVZ) is up 53% over the past year and you're wondering whether the rally still has foundation, that's the question the factor stack actually answers.

The business turning behind the price

Six months ago, Invesco was posting a loss per share. Q2 2025: diluted EPS of minus $0.03. Q2 2026: adjusted diluted EPS of $0.71 — a 97% swing. Revenue grew 20.3% year-over-year to $1.33 billion (adjusted net revenue). The adjusted operating margin expanded to 37.5% from 31.2%.

The inflows are the real story. Q2 delivered a record $45.1 billion in net long-term inflows. The QQQ Invesco product alone brought $13.8 billion in the quarter. ETFs and index products accounted for $30.1 billion of the total. Asia Pacific clients contributed $8.2 billion in Q2 — and in Q1 they led every region with $13.2 billion, including $8.7 billion to the China joint venture.

Assets under management hit $2.47 trillion at June 30, up 23.4% from $2 trillion a year earlier. The stock has moved from $20.67 (52-week low) to $32.78 today.

So the question is no longer whether Invesco is turning around. The question is what the factor stack says at current prices.

The five-factor read

No stock is cheap or strong in isolation. The grade only works relative to a comparison set. I'm using asset management peers: Franklin Templeton (BEN), State Street (STT), Intercontinental Exchange (ICE), and Lazard (LAZ).

Growth: A (12.2% revenue growth, 66.1% FCF growth)

Trailing-twelve-month revenue growth sits at 12.2%. Free cash flow growth is 66.1% year-over-year, with FCF of nearly $2 billion TTM. That's top-quartile growth in the asset management set. ICE is the other high-growth name here; BEN and STT are running single-digit revenue growth. The growth factor supports the thesis — Invesco is genuinely accelerating, not just recovering.

Profitability: B (66.3% gross margin, 37.5% adjusted operating margin)

The adjusted operating margin of 37.5% is the number that matters. It means Invesco keeps 37.5 cents of operating profit for every dollar of revenue after core costs. That's solid for an asset manager and expanding — it was 31.2% a year ago. The GAAP operating margin of minus 9.7% is misleading here; it includes one-time charges and restructuring costs that distort the headline. Looking at it adjusted, the profitability story is strengthening, not static.

ROIC is minus 1.6% and ROE is minus 2.97% on a GAAP basis — both dragged by the same one-time items. The cash flow return on capital is where the real story is, and at $2 billion in FCF against a $14.5 billion market cap, the FCF yield is around 13.5%. That's the durability signal.

Valuation: Mixed (1.07x book, 45.6x forward earnings, 0.27 PEG)

This is where the picture gets complicated. At 1.07x book value, Invesco trades at a discount to BEN (1.20x), STT (1.86x), and ICE (3.04x). Book value is a floor, not a ceiling — and asset managers live and die by the quality of their assets, which for Invesco means those $2.47 trillion in client money. The low P/B suggests the market is still pricing in residual skepticism.

But the forward P/E of 45.6x is expensive. BEN trades at 21.4x, STT at 16.3x, ICE at 22.3x. The forward multiple is pricing in continued acceleration. The PEG ratio of 0.27 pulls back toward cheap territory, suggesting the growth rate justifies a premium — but PEG is more of a directional compass than a precise price tag.

The valuation read: cheap on book, expensive on forward earnings, and justified on a growth-adjusted basis. The market hasn't decided what Invesco is. That ambiguity is where the risk lives.

Momentum: A (53% rolling annual return, 37% over 120 days)

The stock has rallied hard — 53% over the trailing year, 37% over the past 120 days, and 6% over the past 20 days. It's trading at $32.78, just 3% below its 52-week high of $33.66. This is the definition of strong momentum. Momentum is a timing signal, not a thesis. It tells you the market already knows the turnaround story. It doesn't tell you whether there's more room.

Revisions: B+ (earnings trajectory improving sharply)

The earnings path has been the strongest revision signal: from minus $0.03 in Q2 2025 to $0.71 in Q2 2026. Q2 revenue came in at $1.329 billion against a consensus of roughly $1.11 billion — a clear beat. The consensus EPS estimates for the coming quarters (Q3 2025: $0.45, Q4 2025: $0.58, Q1 2026: $0.58, Q2 2026: $0.67) have been systematically beaten or met. Revisions are running in the right direction, but the consensus has already caught up to the good news. The revision upside that existed six months ago has largely been priced in.

Safety: A (net negative debt, $915 million cash)

The balance sheet is clean. Total debt of $14 billion sounds large until you see the $13.5 billion in equity and the $915 million in cash, which puts net debt at minus $746 million — Invesco actually has more liquid assets than debt. The current ratio is 173.8%. Debt-to-equity is 0.12. This is a fortress balance sheet for a financial firm. The 17-year dividend streak and 2.6% yield sit on top of it. Safety is not the headline, but it's the floor that lets you hold through volatility.

What does this mean for the investor?

The factor stack reads: growth A, profitability B, momentum A, revisions B+, safety A, valuation mixed. That's a strong profile. The problem is the price. A stock that has moved 53% and trades just below its 52-week high is asking you to believe the acceleration continues.

The Asia Pacific transition doesn't change the factor stack. It's continuity leadership in the region that was the top source of inflows in Q1 and second in Q2. The China joint venture alone generated $6.9 billion in net long-term inflows last quarter. If Franc maintains that flow machine, the growth factor holds. If it stutters, the revision factor is the first one to turn.

There are two scenarios worth separating. The first is that you're already holding IVZ and bought before the rally. In that case, the factor stack still supports a Hold — momentum is strong, growth is real, and the balance sheet lets you ride through pullbacks. Hold is not Sell. The rating would have to cool further before it becomes a Sell signal.

The second scenario is that you're watching from the sidelines. Here the forward P/E of 45.6x is a real constraint. You're paying a premium multiple for a turnaround that has already happened. The entry at $20 gave you the factor stack at a discount. The entry at $33 gives you the same factor stack at a premium. The P/B of 1.07x is the only remaining valuation cushion, and it tells you the market still hasn't fully embraced the new Invesco. That gap between the book-value discount and the forward-earnings premium is the tension point — resolve toward growth, and the stock has more room. Resolve toward skepticism, and the multiple compresses.

The specific trigger to watch: the next two earnings reports. If Q3 and Q4 2026 beat the already-raised consensus, the growth narrative is confirmed and the forward multiple holds. If they come in line or miss, the revision factor flips and the stock has no valuation cushion left. The earnings timeline for Q3 should land in early October — that's the next data point.

In our book, the factor stack still supports the thesis. The stock has just moved a lot faster than the fundamentals took time to turn. The job now is to watch whether the fundamentals can keep up with the price they've already reached.